GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q1 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,366,000 | +39.6% | 54,314 | +41.3% | 0.45% | +48.5% |
| Q4 2021 | $1,695,000 | +29.5% | 38,437 | +12.2% | 0.30% | +22.5% |
| Q3 2021 | $1,309,000 | +15.0% | 34,260 | +19.8% | 0.25% | +10.2% |
| Q2 2021 | $1,138,000 | +11.9% | 28,591 | +0.4% | 0.23% | +0.4% |
| Q1 2021 | $1,017,000 | +12.1% | 28,483 | +15.5% | 0.22% | +5.6% |
| Q4 2020 | $907,000 | +8.2% | 24,650 | +10.7% | 0.21% | -7.0% |
| Q3 2020 | $838,000 | -7.8% | 22,275 | 0.0% | 0.23% | -17.0% |
| Q2 2020 | $909,000 | +11.5% | 22,275 | +3.6% | 0.28% | -8.9% |
| Q1 2020 | $815,000 | -16.6% | 21,505 | +3.4% | 0.30% | +1.0% |
| Q4 2019 | $977,000 | +0.8% | 20,796 | -8.4% | 0.30% | -3.8% |
| Q3 2019 | $969,000 | -10.4% | 22,701 | -16.0% | 0.31% | -10.3% |
| Q2 2019 | $1,082,000 | -20.2% | 27,041 | -16.6% | 0.35% | -21.4% |
| Q1 2019 | $1,356,000 | +7.7% | 32,441 | -1.5% | 0.44% | -3.1% |
| Q4 2018 | $1,259,000 | -12.9% | 32,951 | -8.4% | 0.46% | +8.3% |
| Q3 2018 | $1,445,000 | -0.9% | 35,981 | -0.6% | 0.42% | -3.0% |
| Q2 2018 | $1,458,000 | -13.5% | 36,181 | -16.1% | 0.44% | -0.5% |
| Q1 2018 | $1,685,000 | -30.7% | 43,131 | -37.0% | 0.44% | -20.8% |
| Q4 2017 | $2,430,000 | +8.3% | 68,506 | +24.0% | 0.55% | +4.7% |
| Q3 2017 | $2,243,000 | -4.5% | 55,256 | +1.4% | 0.53% | -11.1% |
| Q2 2017 | $2,349,000 | -2.7% | 54,481 | -4.9% | 0.59% | -2.9% |
| Q1 2017 | $2,415,000 | -15.6% | 57,283 | -22.9% | 0.61% | -18.2% |
| Q4 2016 | $2,862,000 | -9.1% | 74,320 | +1.9% | 0.75% | -26.4% |
| Q3 2016 | $3,147,000 | -6.9% | 72,960 | -6.4% | 1.02% | +8.2% |
| Q2 2016 | $3,379,000 | +36.0% | 77,960 | +27.2% | 0.94% | +33.2% |
| Q1 2016 | $2,485,000 | -10.3% | 61,280 | -10.7% | 0.70% | -3.4% |
| Q4 2015 | $2,769,000 | +8.9% | 68,630 | +3.7% | 0.73% | -1.9% |
| Q3 2015 | $2,543,000 | -5.2% | 66,150 | +2.7% | 0.74% | +3.8% |
| Q2 2015 | $2,682,000 | -9.1% | 64,400 | +0.7% | 0.72% | -12.0% |
| Q1 2015 | $2,951,000 | +7.4% | 63,945 | -0.6% | 0.81% | +5.4% |
| Q4 2014 | $2,748,000 | – | 64,300 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |